Faktor Risiko Kejadian Covid-19 Di Rumah Sakit Umum Daerah Andi Djemma Masamba
DOI:
https://doi.org/10.33096/j5ag9595Keywords:
Covid-19, Risk, Age, Gender, ComorbidAbstract
Coronaviruses are a large family of viruses that cause mild to severe symptoms. On April 4, 2020, the WHO reported that the number of confirmed positive cases of COVID-19 was 1,056,157 people, with a death toll of 57,130 people. The purpose of this study is to determine the risk factors for the occurrence of COVID-19 at the Andi Djemma Masamba Regional General Hospital in 2021. The type of qualitative research is the case-control study method. The design of this study was carried out by first identifying the group of cases (COVID-19 sufferers) and then looking retrospectively at whether or not there are risk factors that are suspected to play a role. The sample in this study consisted of 352 respondents from Lewenshow's calculation, with a ratio of 1:3, consisting of 88 cases and 264 controls. The analysis used univariate and bivariate analyses with a chi-square correlation test. The results of this study show that age is a protective factor of the incidence of Covid-19 at Andi Djemma Masamba Hospital (OR=0.614; 95%CI=0.312-1.210), gender is a protective factor of the incidence of Covid-19 at Andi Djemma Masamba Hospital (OR=0.463; 95% CI=0.282-0.760), clinical symptoms are a protective factor of the incidence of Covid-19 at Andi Djemma Masamba Hospital (OR=0.020; 95% CI=0.119-0.808), and commobid which is a protective factor of the incidence of Covid-19 at Andi Djemma Masamba Hospital (OR=0.945; 95% CI=0.553-1). 616). The conclusion of this study shows that age, gender, clinical symptoms, and comorbidities are protective factors against the incidence of COVID-19. As a suggestion in this study, it is hoped that people with comorbidities will be able to control their comorbidities, considering that comorbidities are one of the factors that aggravate the incidence of COVID-19.
References
1. H Nawangsari. Hubungan Karakteristik Individu dengan Pengetahuan tentang Pencegahan Coronavirus Disease 2019 pada Masyarakat di Kecamatan Pungging Mojokerto. Sentani Nurs. J., vol. 4, no. 1, pp. 46–51, 2021, doi: 10.52646/snj.v4i1.97.
2. A Zein. Pendeteksian Virus Corona Dalam Gambar X-Ray Menggunakan Algoritma Artificial Intelligence dengan Deep Learning Python. J. Teknol. Inf. ESIT, vol. XV, no. 01, pp. 19–23, 2020, [Online]. Available: http://www.openjournal.unpam.ac.id/index.php/ESIT/article/view/14037
3. S M. Ilpaj., N, Nurwati. Analisis Pengaruh Tingkat Kematian Akibat Covid-19 Terhadap Kesehatan Mental Masyarakat Di Indonesia. Focus J. Pekerj. Sos., vol. 3, no. 1, p. 16, 2020, doi: 10.24198/focus.v3i1.28123.
4. T H. Siagian. Corona Dengan Discourse Network Analysis. J. Kebijak. Kesehat. Indones., vol. 09, no. 02, pp. 98–106, 2020.
5. M. Fadilah., dkk. Analisis Pengetahuan Keluarga Terhadap Penyakit Komorbid Di Era COVID-19 Melalui Seminar Online. J. Ilmu Kesehat., vol. 9, no. 1, pp. 86–93, 2020.
6. Keputusan Menteri Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Corona Virus Disease 2019 (Covid-19). MenKes/413/2020, vol. 2019, p. 207, 2020.
7. J. P. Kesehatan et al. Pendidikan Kesehatan Tetang Bijak Menyikapi COVID 19 dalam Upaya Pencegahan Penyeraban Virus Corona pada Siswa SMK Roudlotul Menurut WHO (2020), kasusCOVID-19 dimulai pada tanggal 31 Desember 2019 di kota Wuhan Provinsi Hubei China terdapat kasus klust,” vol. 4, no. 1, pp. 78–84, 2021.
8. F. R. S. S. Chandrasekhar and Jurusan Teknik Mesin Laily Noor Ikhsanto. Analisis Korelasi Faktor Risiko Kejadian COVID-19 di Ruang Isolasi RSUD Sultan Imanuddin Pangkalan Bun Kota Waringin Barat Kalimantan Tengah,” Liq. Cryst., vol. 21, no. 1, pp. 1–17, 2020.
9. R N. Handayani., E. Prayitno. Kajian Nilai Hematologi Seluler Pasien yang Terkonfirmasi Corona Virus Disease Covid-19. Pros. Saintek Semnas MIPAKes Umr., vol. 2, pp. 232–241, 2021, [Online]. Available: https://ejurnal.umri.ac.id/index.php/Semnasmipakes/article/view/2902/1586
10. A H. Lavan and P. Gallagher. Predicting Risk of Adverse Drug Reactions in Older Adults. Ther. Adv. Drug Saf., vol. 7, no. 1, pp. 11–22, 2016, doi: 10.1177/2042098615615472.
11. Y Cen et al. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study. Clin. Microbiol. Infect., vol. 26, no. 9, pp. 1242–1247, 2020, doi: 10.1016/j.cmi.2020.05.041.
12. C Stewart. Daily new coronavirus (COVID-19) cases in Italy since February 2020 (as of December 3, 2020). WHO, 2020. [Online]. Available: https://www.statista.com/statistics/1101690/coronavirus-new-casesdevelopment- italy/
13. W R. Hidayani. Faktor Faktor Risiko Yang Berhubungan Dengan COVID 19 : Literature Review. J. Untuk Masy. Sehat, vol. 4, no. 2, pp. 120–134, 2020, doi: 10.52643/jukmas.v4i2.1015.
14. J M. Jin et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front. Public Heal., vol. 8, no. April, pp. 1–6, 2020, doi: 10.3389/fpubh.2020.00152.
15. Putri., Putra., Mariko. Artikel penelitian kadar, Hub. Usia, Jenis Kelamin dan Gejala dengan Kejadian COVID-19 di Sumatera barat, vol. 44, no. 2, pp. 104–111, 2021.
16. D. Wang et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit. Care, vol. 24, no. 1, pp. 1–9, 2020, doi: 10.1186/s13054-020-02895-6.
17. Senewe. Hubungan Antara Komorbid dan Perilaku Pencegahab terhadap Kasus COVID-19 di Kota Bogor tahun 2020. 2020.
18. F. Ibrahim., A. Natasha., Y. R. Saharman., P. Sudarmono. Preliminary report of COVID-19 testing: experience of the clinical microbiology laboratory Universitas Indonesia, Jakarta, Indonesia. New Microbes New Infect., vol. 37, no. April, p. 100733, 2020, doi: 10.1016/j.nmni.2020.100733.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Aisyah Al Fitriani, Fatmah Afrianty Gobel, Mansur Sididi, Nur Ulmy Mahmud, Sartika

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.